BOWEL OBSTRUCTION IN HOME-CARE CANCER-PATIENTS - 4 YEARS EXPERIENCE

被引:32
作者
MERCADANTE, S [1 ]
机构
[1] BUCCHERI LA FERLA FATEBENEFRATELLI HOSP, DEPT ANESTHESIA & INTENS CARE, PALERMO, ITALY
关键词
BOWEL OBSTRUCTION; OCTREOTIDE; MORPHINE; HALOPERIDOL; CONSERVATIVE; MANAGEMENT; ABDOMINAL; PAIN VOMITING;
D O I
10.1007/BF00368889
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Conservative management of bowel obstruction in advanced cancer patients has been recognized as efficacious in controlling distressing symptoms such as nausea. vomiting and pain. A retrospective analysis of prevalence, treatment and outcome was performed. A group of 25 patients with signs of bowel obstruction were studied from 1001 consecutive patients receiving palliative care at home. A score for total distress was calculated to assess the gastrointestinal symptoms at diagnosis, after 1 week of treatment and 1 day before death. The mean survival was 19 days. Six patients were admitted to hospital, 3 of whom underwent surgery and died in the immediate postoperative period. The patients diagnosed in hospital and discharged received a nasogastric tube (7 cases) and a central venous line. The nasogastric tube was removed after gastrointestinal secretions had been controlled by a combination of drugs, and parenteral nutrition or hydration, mainly started in hospital, was discontinued only a few days before death (13 cases, mean duration 19 days). The distress symptom score was statistically reduced after 1 week of treatment and on the day before death when compared to the referral time. The most frequent combination of drugs was octreotide, haloperidol and low doses of morphine. A subcutaneous route was preferred for administering the drugs. Utilization of a wide range of drugs permits good symptom control for bowel obstruction in patients followed at home.
引用
收藏
页码:190 / 193
页数:4
相关论文
共 17 条
[1]  
ALLAN SG, 1993, OXFORD TXB PALLIATIV, P282
[2]  
BAINES M, 1985, LANCET, V2, P990
[3]  
Baines MJ, 1993, OXFORD TXB PALLIATIV, P311
[4]  
BRUERA E, 1989, J PAIN SYMPTOM MANAG, V3, P133
[5]   INTESTINAL-OBSTRUCTION IN PATIENTS WITH WIDESPREAD INTRAABDOMINAL MALIGNANCY [J].
CHAN, A ;
WOODRUFF, RK .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1992, 7 (06) :339-342
[6]   CONTINUOUS SUBCUTANEOUS INFUSION OF HYOSCINE BUTYLBROMIDE REDUCES SECRETIONS IN PATIENTS WITH GASTROINTESTINAL OBSTRUCTION [J].
DECONNO, F ;
CARACENI, A ;
ZECCA, E ;
SPOLDI, E ;
VENTAFRIDDA, V .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1991, 6 (08) :484-486
[7]  
Fainsinger R L, 1992, J Palliat Care, V8, P30
[8]   SYMPTOM CONTROL IN TERMINALLY ILL PATIENTS WITH MALIGNANT BOWEL OBSTRUCTION (MBO) [J].
FAINSINGER, RL ;
SPACHYNSKI, K ;
HANSON, J ;
BRUERA, E .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1994, 9 (01) :12-18
[9]  
Isbister W H, 1990, J R Coll Surg Edinb, V35, P369
[10]   PALLIATION OF MALIGNANT INTESTINAL-OBSTRUCTION USING OCTREOTIDE [J].
KHOO, D ;
HALL, E ;
MOTSON, R ;
RILEY, J ;
DENMAN, K ;
WAXMAN, J .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (01) :28-30